Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Clinical trial NCT05429515 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05429515
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma Acute Kidney Injury Hemodiafiltration With Ultrafiltrate Regeneration (HFR)

Start date: 2022-07-01
Primary completion: 2032-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.